Evidence map›Paper›PMID 34099632›Full record

ArticleBone research2021

Targeting angiogenesis for fracture nonunion treatment in inflammatory disease.

Cuicui Wang, Jun Ying, Xiaolei Nie, Tianhong Zhou, Ding Xiao, Gaurav Swarnkar, Yousef Abu-Amer, Jianjun Guan, Jie Shen

Open access · goldAbstract read
In one paragraph

Article in Bone research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Murine Progeria Model Exhibits Delayed Fracture Healing With Senescent Phenotype and Dysregulated Immune Response.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2026
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Cuicui Wang *Department of Orthopaedic Surgery, School of Medicine, Washington University, St. Louis, MO, USA.
Jun Ying *Department of Orthopaedic Surgery, School of Medicine, Washington University, St. Louis, MO, USA.
Xiaolei NieDepartment of Mechanical Engineering & Materials Science, School of Engineering, Washington University, St. Louis, MO, USA.
Tianhong ZhouDepartment of Mechanical Engineering & Materials Science, School of Engineering, Washington University, St. Louis, MO, USA.
Ding XiaoDepartment of Orthopaedic Surgery, School of Medicine, Washington University, St. Louis, MO, USA.
Gaurav SwarnkarDepartment of Orthopaedic Surgery, School of Medicine, Washington University, St. Louis, MO, USA.
Yousef Abu-AmerDepartment of Orthopaedic Surgery, School of Medicine, Washington University, St. Louis, MO, USA.ORCID http://orcid.org/0000-0002-5890-5086
Jianjun GuanDepartment of Mechanical Engineering & Materials Science, School of Engineering, Washington University, St. Louis, MO, USA.
Jie ShenDepartment of Orthopaedic Surgery, School of Medicine, Washington University, St. Louis, MO, USA. shen.j@wustl.edu.
Washington University in St. Louis · USZhejiang Chinese Medical University · CN

Funding

Risk Factors for Cognitive Decline in African-AmericansR01AG022018 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BARNES, LISA L · 2004 to 2025
$18.2M
Resource Based Center for Musculoskeletal Biology and Medicine (Overall Application)P30AR074992 · NIAMS · WASHINGTON UNIVERSITY · PI MATTHEW J SILVA · 2019 to 2026
$6.8M
Racial Differences in Late-Life Cognitive Decline and Risk of Alzheimer's DiseaseRF1AG022018 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BARNES, LISA L · 2016 to 2019
$6.6M
Regulatory Mechanisms of Implant-Induced OsteolysisR01AR049192 · NIAMS · WASHINGTON UNIVERSITY · PI ABU-AMER, YOUSEF · 2004 to 2019
$4.3M
Targeting angiogenesis for fracture nonunion treatment under inflammatory diseasesR01AR077616 · NIAMS · WASHINGTON UNIVERSITY · PI GUAN, JIANJUN, SHEN, JIE · 2020 to 2025
$2.7M
Epigenetic Regulation of Bone Regeneration in Inflammatory DiseaseR01AR075860 · NIAMS · WASHINGTON UNIVERSITY · PI SHEN, JIE · 2019 to 2024
$2.6M
Hydrogel encapsulation of a tissue repair protein to treat chronic woundsR01AG056919 · NIA · OHIO STATE UNIVERSITY · PI GUAN, JIANJUN, LI, HAICHANG · 2017 to 2021
$2.4M
Preservation and Vascularization of Cardiac Extracellular Matrix after Myocardial InfarctionR01HL138175 · NHLBI · WASHINGTON UNIVERSITY · PI GUAN, JIANJUN · 2019 to 2022
$1.8M
Mechanisms of Physiologic and Pathologic OsteoclastogenesisR01AR072623 · NIAMS · WASHINGTON UNIVERSITY · PI ABU-AMER, YOUSEF · 2018 to 2022
$1.7M
Stem Cell Oxygenation and Ischemic Tissue RegenerationR01HL138353 · NHLBI · WASHINGTON UNIVERSITY · PI GUAN, JIANJUN · 2017 to 2020
$1.5M
CONTROL OF CARDIAC FIBROSIS TO PREVENT CARDIAC FUNCTION DETERIORATIONR01EB022018 · NIBIB · WASHINGTON UNIVERSITY · PI GUAN, JIANJUN · 2016 to 2018
$1.1M
Stem cell therapy for fracture nonunion under inflammatory diseasesR21AR077226 · NIAMS · WASHINGTON UNIVERSITY · PI GUILAK, FARSHID, SHEN, JIE · 2020 to 2021
$376k
NHLBI NIH HHS R01 HL138175NHLBI NIH HHS R01 HL138353NIAMS NIH HHS P30 AR074992NIAMS NIH HHS R01 AR049192NIAMS NIH HHS R01 AR072623NIAMS NIH HHS R01 AR075860NIAMS NIH HHS R01 AR077616NIAMS NIH HHS R21 AR077226NIA NIH HHS R01 AG056919NIBIB NIH HHS R01 EB022018Shriners Hospitals for Children 85160U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) AR049192U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) AR072623U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) AR075860U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) AR077226U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) AR077616U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB) AG056919U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB) EB022018U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB) HL138175U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB) HL138353
6 · The paper itself

Abstract

Atrophic fracture nonunion poses a significant clinical problem with limited therapeutic interventions. In this study, we developed a unique nonunion model with high clinical relevance using serum transfer-induced rheumatoid arthritis (RA). Arthritic mice displayed fracture nonunion with the absence of fracture callus, diminished angiogenesis and fibrotic scar tissue formation leading to the failure of biomechanical properties, representing the major manifestations of atrophic nonunion in the clinic. Mechanistically, we demonstrated that the angiogenesis defect observed in RA mice was due to the downregulation of SPP1 and CXCL12 in chondrocytes, as evidenced by the restoration of angiogenesis upon SPP1 and CXCL12 treatment in vitro. In this regard, we developed a biodegradable scaffold loaded with SPP1 and CXCL12, which displayed a beneficial effect on angiogenesis and fracture repair in mice despite the presence of inflammation. Hence, these findings strongly suggest that the sustained release of SPP1 and CXCL12 represents an effective therapeutic approach to treat impaired angiogenesis and fracture nonunion under inflammatory conditions.

Identifiers

PMID34099632
PMCPMC8184936
OpenAlexW3170774376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.